Engaging Hispanic and Latino communities in Alzheimer's disease research
Official title: A Precision Engagement Approach with Hispanics/Latinos for Alzheimer’s Disease Research: ECHAR-PE
Funded at University of Houston · NIH-10930111 · Data updated 2026-11-12
This study is working to make sure that Hispanic and Latino individuals are better represented in Alzheimer's research by understanding their specific needs and values, so that future studies can be more inclusive and relevant to their communities.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Houston NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | September 16, 2023 |
| Project end | August 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $427,980 |
| NIH project number | 5UH2AG083264-02 |
| Project ID | NIH-10930111 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Hispanic and Latino individuals aged 21 and older who are at risk for or diagnosed with Alzheimer's disease or related dementias.
✕Less likely to help
Patients who are not Hispanic or Latino or those who do not have a risk for Alzheimer's disease or related dementias may not benefit from this research.
What this research studies
This research aims to improve the representation of Hispanic and Latino individuals in Alzheimer's disease and related dementias (AD/ADRD) research. It focuses on understanding the unique needs and values of these communities to develop tailored approaches for their inclusion in clinical studies. By addressing systemic barriers and enhancing cultural engagement, the project seeks to create sustainable data resources that reflect the diversity of the population. The methodology involves community outreach and collaboration to ensure that research is relevant and accessible to Hispanic and Latino participants.
Why it matters
Potential benefit: If successful, this research could lead to more effective and culturally appropriate treatments for Alzheimer's disease in Hispanic and Latino populations.
How similar studies have gone: Other research has shown success in improving health outcomes by increasing diversity in clinical trials, indicating that this approach could be effective.
Where this research is happening
-
University of Houston
Houston, United States Active
Researchers
- Principal investigator: Medina, Luis D — University of Houston
- Study coordinator: Medina, Luis D
Related research
Other NIH-funded projects on the same topics.
-
Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model
Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.
-
Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients
A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s
A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.
-
Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health
Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.
-
Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues
Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.